Kelly Wilson
Direttore operativo presso BIOSTAX CORP.
Patrimonio netto: 671 165 $ in data 31/05/2024
Profilo
Kelly O’Brien Wilson currently works at Forte Animal Health, Inc., as Director from 2020 and Biostax Corp., as Chief Operating Officer from 2022.
Ms. Wilson also formerly worked at Biostax Corp., as CTO & Director-Human Resources from 2015 to 2020, Biostax Corp., as Chief Executive & Operating Officer in 2023, and Cytocom, Inc., as Chief Technology & Information Officer from 2016 to 2020.
Ms. Wilson received her undergraduate degree and graduate degree from the University of Central Florida.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BIOSTAX CORP
18.65% | 28/03/2024 | 15 608 498 ( 18.65% ) | 671 165 $ | 31/05/2024 |
Posizioni attive di Kelly Wilson
| Società | Posizione | Inizio |
|---|---|---|
| BIOSTAX CORP. | Direttore operativo | 01/08/2022 |
| Forte Animal Health, Inc. | Direttore/Membro del Consiglio | 01/12/2020 |
Precedenti posizioni note di Kelly Wilson
| Società | Posizione | Fine |
|---|---|---|
| BIOSTAX CORP. | Amministratore Delegato | 25/07/2023 |
| BIOSTAX CORP. | Direttore Tecnico/Scientifico/R&S | 01/04/2020 |
Cytocom, Inc. /Old/
 Cytocom, Inc. /Old/ BiotechnologyHealth Technology Cytocom, Inc. operates as biotech company which specializes in repurposing of drugs that deploys patented therapies and develops novel immune therapies. The company was founded by Noreen M. Griffin and is headquartered in Winter Park, FL. | Direttore Tecnico/Scientifico/R&S | 01/04/2020 |
Formazione di Kelly Wilson
| University of Central Florida | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOSTAX CORP. | Health Technology |
| Aziende private | 2 |
|---|---|
Cytocom, Inc. /Old/
Cytocom, Inc. /Old/ BiotechnologyHealth Technology Cytocom, Inc. operates as biotech company which specializes in repurposing of drugs that deploys patented therapies and develops novel immune therapies. The company was founded by Noreen M. Griffin and is headquartered in Winter Park, FL. | Health Technology |
| Forte Animal Health, Inc. |
- Borsa valori
- Insiders
- Kelly Wilson
